Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism

Until recently, the standard treatment of chronic hepatitis C virus (HCV) infection was a combination therapy with PEG-IFN-α plus ribavirin. Previous studies have proven that several markers predict the outcome of such therapy, e.g., pretreatment plasma levels of interferon inducible protein IP-10,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoller, Heinz, Jenal, Annina, Staettermayer, Albert F., Schroecksnadel, Sebastian, Ferenci, Peter, Fuchs, Dietmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491665/
https://www.ncbi.nlm.nih.gov/pubmed/26096654
http://dx.doi.org/10.3390/ph8020337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491665/
https://www.ncbi.nlm.nih.gov/pubmed/26096654
http://dx.doi.org/10.3390/ph8020337

Ejemplares similares